These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8359914)

  • 1. Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells.
    Miyoshi-Akiyama T; Imanishi K; Uchiyama T
    Infect Immun; 1993 Sep; 61(9):3922-7. PubMed ID: 8359914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
    Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
    J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of a product from Salmonella typhimurium with the ability to inhibit mitogen-induced proliferation of murine splenic T-lymphocytes.
    Matsui K
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):155-60. PubMed ID: 8731024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
    Ueshiba H; Kato H; Miyoshi-Akiyama T; Tsubokura M; Nagano T; Kaneko S; Uchiyama T
    Zentralbl Bakteriol; 1998 Oct; 288(2):277-91. PubMed ID: 9809408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
    Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
    J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen.
    Ramamurthy T; Yoshino K; Abe J; Ikeda N; Takeda T
    FEBS Lett; 1997 Aug; 413(1):174-6. PubMed ID: 9287138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
    Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
    J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
    Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
    J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.
    Goubard A; Loïez C; Abe J; Fichel C; Herwegh S; Faveeuw C; Porte R; Cayet D; Sebbane F; Penet S; Foligné B; Desreumaux P; Saito H; Sirard JC; Simonet M; Carnoy C
    Infect Immun; 2015 May; 83(5):2053-64. PubMed ID: 25754199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for superantigen production by Yersinia pseudotuberculosis.
    Abe J; Takeda T; Watanabe Y; Nakao H; Kobayashi N; Leung DY; Kohsaka T
    J Immunol; 1993 Oct; 151(8):4183-8. PubMed ID: 8409395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of murine T cells reactive with the bacterial superantigen Yersinia pseudotuberculosis-derived mitogen (YPM) and factors involved in YPM-induced toxicity in mice.
    Miyoshi-Akiyama T; Fujimaki W; Yan XJ; Yagi J; Imanishi K; Kato H; Tomonari K; Uchiyama T
    Microbiol Immunol; 1997; 41(4):345-52. PubMed ID: 9159409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
    Yoshino K; Takao T; Ishibashi M; Samejima Y; Shimonishi Y; Takeda T
    FEBS Lett; 1996 Jul; 390(2):196-8. PubMed ID: 8706858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and partial characterization of a soluble hemagglutinin from Yersinia pseudotuberculosis.
    Takumi K; Koga T; Oka T; Takeoka A; Tsubokura M; Sheng YJ
    Microbiol Immunol; 1991; 35(4):343-7. PubMed ID: 1943846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
    Yoshino K; Abe J; Murata H; Takao T; Kohsaka T; Shimonishi Y; Takeda T
    FEBS Lett; 1994 Dec; 356(1):141-4. PubMed ID: 7988709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen.
    Donnelly GA; Lu J; Takeda T; McKay DM
    J Infect Dis; 1999 Nov; 180(5):1590-6. PubMed ID: 10515820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T cells and gamma interferon in Yersinia pseudotuberculosis-derived mitogen (YPM)-induced toxicity in mice.
    Kano H; Ito Y; Matsuoka K; Iwata T; Saito H; Kohsaka T; Abe J
    Adv Exp Med Biol; 2003; 529():137-9. PubMed ID: 12756745
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of stimulation of T cells by Streptococcus pyogenes: isolation of a major mitogenic factor, cytoplasmic membrane-associated protein.
    Itoh T; Satoh H; Isono N; Rikiishi H; Kumagai K
    Infect Immun; 1992 Aug; 60(8):3128-35. PubMed ID: 1639482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray analysis of Yersinia pseudotuberculosis-derived mitogen.
    Donadini R; Wåhlberg M; Kohsaka T; Ito Y; Fields BA
    Acta Crystallogr D Biol Crystallogr; 2003 Jul; 59(Pt 7):1330-2. PubMed ID: 12832802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
    Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
    Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.